SCHEMBL4096953

SCHEMBL4096953

Nc1c(Cl)cccc1C(=O)Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
TSHR P16473 2/20 0.47
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
ALOX15 P16050 1/20 0.43
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.42
CYP1A2 P05177 1/20 0.41
HPGD P15428 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 2/20 0.41
HAVCR2 Q8TDQ0 1/20 0.41
G6PD P11413 1/20 0.41
CASP7 P55210 1/20 0.41
CASP6 P55212 1/20 0.41
KDM4E B2RXH2 3/20 0.41
LMNA P02545 3/20 0.40
GAA P10253 1/20 0.40
MEN1 O00255 1/20 0.38
ERCC5 P28715 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146560 0.83 TSHR (0.63) ALDH1A1TSHRCES2CES1ALOX15
SCHEMBL161331 0.83 KDM4E (0.53) ALDH1A1TSHRCES2CES1POLB
SCHEMBL1189439 0.81 TSHR (0.45) ALDH1A1TSHRCES2CES1POLB
SCHEMBL2473273 0.80 MMP2 (0.47) ALDH1A1TSHRALOX15RECQLHPGD
SCHEMBL29016414 0.78 HDAC8 (0.47) ALDH1A1TSHRCES2CES1POLB
SCHEMBL2533018 0.78 ALDH1A1 (0.47) ALDH1A1TSHRCES2CES1POLB
SCHEMBL28234218 0.78 TSHR (0.42) ALDH1A1TSHRCES2CES1POLB
SCHEMBL93365 0.77 TSHR (0.68) ALDH1A1TSHRCES2CES1ALOX15
SCHEMBL3917269 0.77 ALDH1A1 (0.42) ALDH1A1TSHRALOX15HPGDKMT2A
SCHEMBL28144990 0.77 MAPT (0.43) ALDH1A1TSHRCES2CES1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232531-A A kind of preparation method of the card than replacing Buddhist nun 安庆奇创药业有限公司 2019-01-18 CN claimed
CN-109232531-A A kind of preparation method of the card than replacing Buddhist nun 安庆奇创药业有限公司 2019-01-18 CN disclosed
CN-104496967-A Substituent N heterozygous aromatic base amide compound and application thereof UNIV NANKAI 2015-04-08 CN disclosed
US-20090209536-A1 AMINOQUINAZOLINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-08-20 US disclosed
WO-2008157500-A1 AMINOQUINAZOLINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2008-12-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209536-A1 AMINOQUINAZOLINE CANNABINOID RECEPTOR MODULATORS FOR TREATMENT OF DISEASE CNR2, CNR1, GPR18 ALDH1A1 4857/4885TSHR 3396/4885CES2 3628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.